Abstract-Thromboxane (TX) A 2 is released from multiple cell types and is a prime mediator of the pathogenesis of many vascular events, including angiogenesis. Endothelial cells express TXA 2 receptors (TP) but the effects of TP stimulation on angiogenesis remain controversial. In this study, we show that stimulation of endothelial cell TP impairs ligand-induced FGF receptor internalization and consequently abrogates FGF-2-induced endothelial cell migration in vitro and angiogenesis in vivo. Prevention of FGF-2-induced angiogenesis was associated with expression of the TP isoform. The deficit in FGFR1 internalization was mediated through activation of TP preventing the FGF-2-mediated decrease in p53 expression, thus enhancing thrombospondin-1 (TSP-1) release from EC and reducing FGFR1 internalization. Once released TSP-1 interacted with the ␣ v  3 integrin on the EC surface. On stimulation, FGFR1 and ␣ v  3 were found to associate in a complex. We determined that complex formation was important for receptor internalization as conditions that inhibit FGFR1 internalization, such as inappropriate ligation of ␣ v  3 by either TSP-1 or a neutralizing antibody, disrupted the complex. These results establish a novel role for isoform specific regulation of angiogenesis by TP, provide the first functional significance for the existence of two TP isoforms in humans, and clarify the mechanism by which TP signaling regulates FGFR1 kinetics and signaling. A ngiogenesis is central to the pathogenesis of, and recovery from, multiple disease processes, including ischemia and cancer. Elevated levels of one angiogenic factor, fibroblast growth factor-2 (FGF-2), have been documented in acute ischemic coronary syndromes. 1,2 Serum FGF-2 levels are first detectable in the acute phase of AMI and are maintained for at least 14 days after the onset of ischemia. 3 In vivo studies suggest that the cardioprotective effects of FGF-2 are significantly correlated with its ability to stimulate angiogenesis. 4,5 Interestingly, the highest FGF-2 levels occur at the time of the most intense angiogenic response after ischemia in the myocardium. These data suggest that FGF-2 may modulate the angiogenic response to ischemic episodes 3 in which new vessels are formed in the coronary collateral circulation and (partially) revascularize the heart. 6 Integrin-mediated outside-in signals cooperate with growth factor receptors to promote cell proliferation and motility. Ligation of the integrin ␣ v  3 is crucial for endothelial cell adhesion to matrix, and for migration and proliferation during angiogenesis. 7,8 Indeed, ␣ v  3 has become a prominent target for antiangiogenic therapy because of its importance to the angiogenic response. The angiogenic activity of FGF-2 is mediated, in part, through activation of ␣ v  3 . 9,10 The integrin ␣ v  3 contributes to distinct pathways of FGF-induced angiogenesis, including activation of the Ras/ERK 11 and Src/FAK 12 signaling pathways, and has been proposed to augment the signaling of FGF to strengt...